{"id":58305,"date":"2023-10-26T19:01:50","date_gmt":"2023-10-26T17:01:50","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\/"},"modified":"2023-10-26T19:01:50","modified_gmt":"2023-10-26T17:01:50","slug":"fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\/","title":{"rendered":"Fore Genomics Launches FORESITE 360 100% DNA Test for Advanced Newborn Screening Using Whole Genome Sequencing (WGS) with 1:1 Genetic Counseling Services"},"content":{"rendered":"
\n

\nAdvanced Newborn Screening with Whole Genome Sequencing Helps Identify 300+ Clinically Manageable Conditions, 40+ Medication Interactions, and Could Be Used to Guide a Lifetime of Precision Health Decisions with One Simple 100% DNA Test After Birth<\/i><\/p>\n

SAN DIEGO–(BUSINESS WIRE)–Fore Genomics, Inc. announced the launch of its revolutionary FORESITE 360\u2122 service using whole genome sequencing (WGS) today, which gives you a complete map (100%) of your baby\u2019s DNA with a simple at-home collection kit. FORESITE 360\u2122 is a 100% DNA test more advanced than basic newborn screening, opening a road to making healthier choices for their future.<\/p>\n

<\/a>
<\/a><\/p>\n

\nWith clinical precision in a simple 100% DNA test, FORESITE 360\u2122 allows you to see which genetically linked and clinically manageable diseases your baby might have now or could develop later. FORESITE 360\u2122 also allows you to see how your baby will respond to common medications. Just obtain a saliva sample and send to Fore\u2019s processing labs for your baby\u2019s genomic profile to be sequenced with whole genome sequencing and screened against 300+ genetically linked and manageable diseases and 40 medication types, and you and your family physician receive a clinical report with any findings to review 1:1 with your personal genetic counselor. FORESITE 360\u2122 is more comprehensive than newborn screening because it uses whole genome sequencing through a simple, at-home 100% DNA test you can order online via www.foresite360.com<\/a>.<\/p>\n

\n100% DNA test: Know More. Know Early. Know What to Do. That\u2019s FORESITE 360\u2122.<\/a><\/p>\n

\nA popular non-clinical 100% DNA test like 23andMe\u00ae and Ancestry\u00ae uses only a fraction of your DNA. FORESITE 360\u2122 screens healthy newborns, infants, and children using whole genome sequencing (WGS) via a parent-initiated telemedicine platform. FORESITE 360\u2122 is physician-ordered with clinical reporting, but it\u2019s easy to buy online through the FORESITE 360\u2122 website.<\/p>\n

\nBasic newborn screening varies from state to state and consists of screening for a few dozen conditions that would be best to know early in life to improve health outcomes, widely considered one of the most successful public health programs in U.S. history. Newborn screening is generally free, but extremely limited in scope. Think of FORESITE 360\u2122 like advanced newborn screening. Parents who want to know as much as they can, as soon as they can, about conditions their child may develop in the first two decades of life want whole genome sequencing with FORESITE 360\u2122.<\/p>\n

\nFORESITE 360\u2122 whole genome sequencing never changes, you\u2019ll receive annual information about new genetically linked health risks. There are billions of dollars invested annually in research, with new gene-disease validations every year that could affect your child\u2019s health. Without whole genome sequencing from FORESITE 360\u2122 which is vastly more comprehensive than basic newborn screening \u2013 your children could suffer unnecessarily for years without access to this vital health information. One simple, at-home 100% DNA test with FORESITE 360\u2122 is all you need for a lifetime of insights, unlocking the power of whole genome sequencing.<\/p>\n

\nWant to learn more: FREE Parent\u2019s Guide to Newborn and Infant Genomics<\/b><\/a><\/p>\n

\nFORESITE 360\u2122, by Fore Genomics, Inc. is a health information service for healthy newborns, infants, children, and their families that uses genetics to plan for their future health through a simple 100% DNA test ordered online. FORESITE 360\u2122 is a self-pay product, available to parents who want more information than limited newborn screening. FORESITE 360\u2122 is a 100% DNA test that uses whole genome sequencing to unlock a lifetime of health information and clinical reporting.<\/p>\n

Contacts<\/b> <\/p>\n

\nPress Inquiries
\n
mjpelo@foregenomics.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Advanced Newborn Screening with Whole Genome Sequencing Helps Identify 300+ Clinically Manageable Conditions, 40+ Medication Interactions, and Could Be Used to Guide a Lifetime of Precision Health Decisions with One Simple 100% DNA Test After Birth SAN DIEGO–(BUSINESS WIRE)–Fore Genomics, Inc. announced the launch of its revolutionary FORESITE 360\u2122 service using whole genome sequencing (WGS) … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-58305","6":"format-standard","7":"category-industry"},"yoast_head":"\nFore Genomics Launches FORESITE 360 100% DNA Test for Advanced Newborn Screening Using Whole Genome Sequencing (WGS) with 1:1 Genetic Counseling Services - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fore Genomics Launches FORESITE 360 100% DNA Test for Advanced Newborn Screening Using Whole Genome Sequencing (WGS) with 1:1 Genetic Counseling Services - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Advanced Newborn Screening with Whole Genome Sequencing Helps Identify 300+ Clinically Manageable Conditions, 40+ Medication Interactions, and Could Be Used to Guide a Lifetime of Precision Health Decisions with One Simple 100% DNA Test After Birth SAN DIEGO–(BUSINESS WIRE)–Fore Genomics, Inc. announced the launch of its revolutionary FORESITE 360\u2122 service using whole genome sequencing (WGS) ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-26T17:01:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20231024510571\/en\/1924112\/21\/Foresite_360_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Fore Genomics Launches FORESITE 360 100% DNA Test for Advanced Newborn Screening Using Whole Genome Sequencing (WGS) with 1:1 Genetic Counseling Services\",\"datePublished\":\"2023-10-26T17:01:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\\\/\"},\"wordCount\":575,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231024510571\\\/en\\\/1924112\\\/21\\\/Foresite_360_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\\\/\",\"name\":\"Fore Genomics Launches FORESITE 360 100% DNA Test for Advanced Newborn Screening Using Whole Genome Sequencing (WGS) with 1:1 Genetic Counseling Services - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231024510571\\\/en\\\/1924112\\\/21\\\/Foresite_360_Logo.jpg\",\"datePublished\":\"2023-10-26T17:01:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231024510571\\\/en\\\/1924112\\\/21\\\/Foresite_360_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20231024510571\\\/en\\\/1924112\\\/21\\\/Foresite_360_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fore Genomics Launches FORESITE 360 100% DNA Test for Advanced Newborn Screening Using Whole Genome Sequencing (WGS) with 1:1 Genetic Counseling Services\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fore Genomics Launches FORESITE 360 100% DNA Test for Advanced Newborn Screening Using Whole Genome Sequencing (WGS) with 1:1 Genetic Counseling Services - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\/","og_locale":"en_US","og_type":"article","og_title":"Fore Genomics Launches FORESITE 360 100% DNA Test for Advanced Newborn Screening Using Whole Genome Sequencing (WGS) with 1:1 Genetic Counseling Services - Pharma Trend","og_description":"Advanced Newborn Screening with Whole Genome Sequencing Helps Identify 300+ Clinically Manageable Conditions, 40+ Medication Interactions, and Could Be Used to Guide a Lifetime of Precision Health Decisions with One Simple 100% DNA Test After Birth SAN DIEGO–(BUSINESS WIRE)–Fore Genomics, Inc. announced the launch of its revolutionary FORESITE 360\u2122 service using whole genome sequencing (WGS) ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\/","og_site_name":"Pharma Trend","article_published_time":"2023-10-26T17:01:50+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20231024510571\/en\/1924112\/21\/Foresite_360_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Fore Genomics Launches FORESITE 360 100% DNA Test for Advanced Newborn Screening Using Whole Genome Sequencing (WGS) with 1:1 Genetic Counseling Services","datePublished":"2023-10-26T17:01:50+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\/"},"wordCount":575,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231024510571\/en\/1924112\/21\/Foresite_360_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\/","url":"https:\/\/pharma-trend.com\/en\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\/","name":"Fore Genomics Launches FORESITE 360 100% DNA Test for Advanced Newborn Screening Using Whole Genome Sequencing (WGS) with 1:1 Genetic Counseling Services - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20231024510571\/en\/1924112\/21\/Foresite_360_Logo.jpg","datePublished":"2023-10-26T17:01:50+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20231024510571\/en\/1924112\/21\/Foresite_360_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20231024510571\/en\/1924112\/21\/Foresite_360_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/fore-genomics-launches-foresite-360-100-dna-test-for-advanced-newborn-screening-using-whole-genome-sequencing-wgs-with-11-genetic-counseling-services\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Fore Genomics Launches FORESITE 360 100% DNA Test for Advanced Newborn Screening Using Whole Genome Sequencing (WGS) with 1:1 Genetic Counseling Services"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58305","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=58305"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/58305\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=58305"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=58305"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=58305"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}